Cargando…
Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy
BACKGROUND: Hemoglobin (Hgb) concentration at diagnosis is associated with outcome in cancer. In a recently reported simplified 3-factor prognostic score in Hodgkin lymphoma, Hgb, along with age and clinical stage, outperformed the classical International Prognostic Score with seven parameters. METH...
Autores principales: | Clausen, Michael R, Maurer, Matthew J, Ulrichsen, Sinna Pilgaard, Larsen, Thomas S, Himmelstrup, Bodil, Rønnov-Jessen, Dorthe, Link, Brian K, Feldman, Andrew L, Slager, Susan L, Nowakowski, Grzegorz S, Thompson, Carrie A, Pedersen, Per Trøllund, Madsen, Jakob, Pedersen, Robert S, Gørløv, Jette Sønderskov, Cerhan, James R, Nørgaard, Mette, D’Amore, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861518/ https://www.ncbi.nlm.nih.gov/pubmed/31814771 http://dx.doi.org/10.2147/CLEP.S219595 |
Ejemplares similares
-
Simplicity at the cost of predictive accuracy in diffuse large B‐cell lymphoma: a critical assessment of the R‐IPI, IPI, and NCCN‐IPI
por: Biccler, Jorne, et al.
Publicado: (2017) -
Interim (18)F-FDG PET/CT improves the prognostic value of S-IPI, R-IPI and NCCN-IPI in patients with diffuse large B-cell lymphoma
por: Jiang, Maoqing, et al.
Publicado: (2017) -
Use of risk-adjusted CUSUM charts to monitor 30-day mortality in Danish hospitals
por: Rasmussen, Thomas Bøjer, et al.
Publicado: (2018) -
PB2103: CAN WE ACCURATELY PREDICT SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA IN THE RITUXIMAB ERA? RETROSPECTIVE COMPARISON OF IPI, AAIPI, R-IPI AND NCCN-IPI
por: Chorão, P., et al.
Publicado: (2022) -
IPI、NCCN-IPI及年龄调整的IPI评分系统在弥漫大B细胞淋巴瘤患者中的预后价值比较
Publicado: (2018)